Novamind Hosts Pioneering Psychedelic Clinical Trial for Opioid Use Disorder
Novamind (NM) is hosting a first-of-its-kind study to find out.
The trial will see if ketamine-assisted therapy can enhance the effectiveness of buprenorphine, a first-line addiction medication, in treating opioid use disorder.
Will the two drugs finally be able to conquer this treatment-resistant condition?
